Performance Measures
American Recovery and Reinvestment Act (ARRA) Healthcare-associated Infections (HAI) DHQP Performance Measures: FY10 Q2 (01/01/10 – 03/31/10)
Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)
$39.8 million to 51 total grantees (49 states; Washington, DC; and Puerto Rico)
Activity A (# grantees = 48)
Percentage of grantees submitting state HAI plans to HHS
- 48 ÷ 48 total grantees = 100%
Percentage of grantees with approved state HAI plans
- 48 ÷ 48 total grantees =100%
Percentage of grantees with a HAI prevention coordinator in place
- 48 ÷ 48 grantees funded for Activity A = 100%
Activity B (# grantees = 31)
Percentage of all hospitals participating in NHSN (sum of all NHSN HOSP categories ÷ 2008 AHA data)
- 2,154 ÷ 4785 total hospitals (of 31 grantees funded for Activity B) = 45.0%.
Percentage of grantees in which 80% or more of hospitals are participating in NHSN
- 6 ÷ 31 grantees funded for Activity B = 19.4%.
Activity C (# grantees = 28)
Number of grantees with 1 or more new or expanded HAI prevention collaboratives possessing all 4 key attributes of a strong prevention collaborative (Multidisciplinary Oversight/Advisory Group; Staffing; Communication Strategy; Outcome Measurement System) = 17
- Total number of new or expanded collaboratives possessing all 4 key attributes = 31
Number of grantees with 1 or more new or expanded HAI prevention collaboratives possessing at least 1 of the 4 key attributes of a strong prevention collaborative* (see above) = 18
- Total number of new or expanded collaboratives possessing at least 1 of the 4 key attributes = 33
All Grantees
Percentage of grantees that have a standardized infection ratio (SIR) that is significantly less than 1 (of grantees submitting enough data to produce a reliable SIR), for the following HAI types: CLABSI and SSI
- Data are not yet applicable to ARRA funding, due to 6-month lag period
Emerging Infections Program (EIP)
$4 million to 10 total grantees (states: CA, CO, CT, GA, MD, MN, NM, NY, OR, TN)
Percentage of research questions addressed in reports of funded projects
- Projects are in developmental stages; data will be summarized at end of ARRA funding period
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - Contact CDC–INFO